Skip to main content
Focused investors/ValueAct Capital

ValueAct Capital

As of Q2 2026, ValueAct Capital reported 18 long-equity positions worth $5.63B in aggregate.

Copy-investor backtest

Latest quarter
+11.81%
1-year
-6.13%
3-year
+68.78%
5-year
+54.42%
3-year vs S&P 500
-4.46%
5-year vs S&P 500
-19.26%
5-year top 5
+37.05%

Return from mechanically copying the disclosed 13F equity portfolio after each filing and rebalancing at the next. The vs S&P 500 figures subtract SPY over that manager's own rebalance dates, so both sides cover the same days; both are price return, excluding dividends. Method & limitations.

Get email alerts when ValueAct Capital files a new 13F — sign in or create a free account.

Updated 2026-06-06 from SEC 13F data.

Live quotes available for 10 of 15 rows. Rows without a quote are marked unavailable.

1STXSEAGATE TECHNOLOGY PLC20.61%Reduce -23.7%23,011,223$1.77B$76.7552w: $43.53 - $78.04; reported $76.75
2CCITIGROUP INC18.44%Reduce -19.6%21,723,719$1.58B$72.7552w: $36.67 - $76.13; reported $72.75
3KKRKKR & CO INC18.01%Reduce -17.0%31,584,672$1.54B$48.8552w: $21.12 - $49.79; reported $48.85
4LKQLKQ CORP10.65%-21,547,746$912.12M$42.3352w: $17.09 - $44.88; reported $42.33
5CBRECBRE GROUP INC9.45%-10,229,820$809.28M$79.1152w: $33.03 - $82.05; reported $79.11
6TRNTRINITY INDS INC7.68%Reduce -14.4%23,105,855$658.29M$28.4952w: $14.53 - $33.77; reported $28.49
7BHCBAUSCH HEALTH COS INC6.65%-17,941,603$569.47M$31.7452w: $12.97 - $34.80; reported $31.74
8SLMSLM CORP5.51%Reduce -18.6%26,294,254$472.51M$17.9752w: $6.06 - $18.28; reported $17.97
9NSITINSIGHT ENTERPRISES INC1.23%New1,100,000$104.96M$95.4252w: $38.34 - $100.09; reported $95.42
10FIFISERV INC1.19%Add +162.0%860,000$102.37MNo quoteNo quote
11BLDTOPBUILD CORP0.54%New221,770$46.45MNo quoteNo quote
12OUTOUTFRONT MEDIA INC0.04%New157,448$3.44M$21.8352w: $9.59 - $25.20; reported $21.83
13CBAHWSCBRE ACQUISITION HLDGS INC0.00%New18,417$17KNo quoteNo quote
15MSMORGAN STANLEY-Sold0$0No quoteNo quote
14CDWCDW CORP-Sold0$0No quoteNo quote